Moclobemide Capsules

This product is a monoamine oxidase inhibitor antidepressant. It works by reversibly inhibiting type A monoamine oxidase in the brain, thereby increasing the levels of norepinephrine, dopamine and 5-hydroxytryptamine in the brain, playing an antidepressant role. It has the characteristics of fast action and rapid recovery of monoamine oxidase activity after discontinuation of the drug.

The main ingredient of this product and its chemical name are: Moclobemide, and its chemical name is: 4-chloro-N-[2-(4-morpholinoethyl)]-benzamide.

This product is a capsule, and the contents are white powder.

depression.

The initial oral dose is 50mg-100mg once, 2-3 times a day, and gradually increased to 150mg-450mg a day, with the highest dose being 600mg a day.

There are mild nausea, dry mouth, headache, dizziness, sweating, palpitations, insomnia, postural hypotension, etc. Taking it with foods high in tyramine (such as cheese) may cause hypertension. Rare adverse reactions include allergic rashes. Occasionally, there are disturbances of consciousness and liver damage. Large doses may induce epilepsy.

1. Patients with mania, pheochromocytoma, and hyperthyroidism are prohibited from using this product. 2. Patients who are allergic to this product are prohibited from using this product.

Precautions for children: Do not use. Precautions for pregnancy and lactation: Pregnant women should use with caution. Lactating women should stop breastfeeding when using this product. Precautions for the elderly: Reduce the dosage as appropriate.

When used in combination with cimetidine, the metabolism of this product can be slowed down.

Keep away from light and store in sealed container.

0.1g

24 months

Yangtze River Pharmaceutical (Group) Co., Ltd.

• Founded in:

  2001-03-27

• Address:

  No. 1, South Yangtze River Road, Taizhou

• Tax NO.:

  913212007286987632

• Registered Funds:

  133 million yuan

• Website:

  Log in to view

• Email:

  Log in to view